TNIP1 Antibody is a polyclonal rabbit antibody designed to target the tumor necrosis factor α–induced protein 3-interacting protein 1 (TNIP1), a critical regulator of immune signaling pathways. It is widely used in research to study TNIP1’s role in NF-κB inhibition, retinoic acid receptor repression, and autoimmune diseases .
Detects TNIP1 protein in human and mouse samples via Western blotting (WB), immunohistochemistry (IHC), immunofluorescence (IF), immunoprecipitation (IP), and ELISA.
Validates TNIP1 expression levels in studies of inflammation, apoptosis, and cancer .
Detects TNIP1 in lysates of peripheral blood lymphocytes, spleen, and skeletal muscle .
Example: Demonstrated TNIP1 overexpression in HeLa cells treated with all-trans retinoic acid (ATRA) .
Stains TNIP1 in paraffin-embedded tissues, including skin keratinocytes and squamous cell carcinoma samples .
TNIP1 antibodies identified elevated TNIP1 expression in systemic autoimmune disorders linked to IgG4 elevation .
TNIP1 knockdown via shRNA in breast cancer cells (MCF-7, T47D) induced growth arrest and apoptosis, suggesting TNIP1 as a potential biomarker .
TNIP1 silencing in keratinocytes enhanced C. acnes-induced NF-κB activation, linking TNIP1 to acne vulgaris pathogenesis .
Affinity Biosciences. (2022). TNIP1 Antibody (Catalog DF12778). [Accessed 2025-03-15].
Proteintech. (2025). TNIP1 Antibody (Catalog 15104-1-AP). [Accessed 2025-03-15].
Xiahe Publishing. (2024). TNIP1 Knockdown Induces Growth Arrest and Apoptosis. OnA. [Accessed 2025-03-15].
Nature. (2024). A TNIP1-Driven Systemic Autoimmune Disorder. Nat. Immunol. [Accessed 2025-03-15].
Frontiers in Immunology. (2018). TNIP1 Regulates Cutibacterium acnes-Induced Innate Immune Responses. [Accessed 2025-03-15].